Diaceutics PLC (AIM:DXRX)

Diaceutics Balance Sheet

Financials in millions GBP. Fiscal year is January - December.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	7.34	12.74	16.67	19.84	19.68
Cash & Short-Term Investments	7.34	12.74	16.67	19.84	19.68
Cash Growth	-42.37%	-23.54%	-16.00%	0.84%	-22.10%
Accounts Receivable	21.26	16.04	11.37	9.21	7.62
Other Receivables	0.76	0.74	0.01	1.85	2.77
Total Trade Receivables	22.02	16.79	11.37	11.06	10.39
Total Current Assets	29.36	29.53	28.04	30.9	30.06
Net Property, Plant & Equipment	1.66	1.68	1.9	2.09	2.13
Other Intangible Assets	16.08	15.41	15.26	15.22	12.82
Other Long-Term Assets	2.9	2	1.14	0.05	0
Total Assets	50.01	48.62	46.34	48.26	45.01

Liabilities

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	8.25	7.61	4.24	3.63	2.36
Current Portion of Long-Term Debt	-	-	-	-	0.13
Current Portion of Leases	0.27	0.15	0.15	0.12	0.15
Other Current Liabilities	0.03	0	-	-	-
Total Current Liabilities	8.55	7.77	4.38	3.75	2.63
Long-Term Leases	0.88	0.91	1.06	1.21	1.29
Other Long-Term Liabilities	0.1	0.09	0.12	0.79	0.45
Total Long-Term Liabilities	0.98	1	1.18	1.99	1.73
Total Liabilities	9.53	8.76	5.56	5.74	4.36

Shareholders' Equity

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0.17	0.17	0.17	0.17	0.17
Treasury Stock	-0.31	-0.31	-0.31	-0.26	-0.17
Additional Paid-in Capital	-	-	37.13	37.13	36.86
Accumulated Other Comprehensive Income	-0.98	-0.63	-0.24	0.14	-0.3
Retained Earnings	41.6	40.63	4.04	5.34	4.08
Shareholders' Equity	40.48	39.86	40.79	42.51	40.65
Total Liabilities & Equity	50.01	48.62	46.34	48.26	45.01

Additional Metrics

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1.15	1.06	1.21	1.33	1.56
Net Cash (Debt)	6.19	11.68	15.46	18.51	18.11
Net Cash Growth	-47.00%	-24.43%	-16.48%	2.20%	-27.94%
Net Cash Per Share	0.07	0.14	0.18	0.21	0.21
Book Value	40.48	39.86	40.79	42.51	40.65
Book Value Per Share	0.48	0.47	0.48	0.49	0.48
Tangible Book Value	24.4	24.44	25.52	27.29	27.83
Tangible Book Value Per Share	0.29	0.29	0.30	0.32	0.33

Data Source: Fiscal.ai Last updated: May 26, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Aug 7, 2026

Data Sources Report a data error